PET scan with a new tracer for pancreatic, lung, or colorectal cancer
Part of Cancer clinical trials.
This study uses a special PET scan with a tracer called 68Ga-NOTA-H006 to look for cancer in people with pancreatic, lung, or colorectal cancer. It may help doctors see the cancer more clearly.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- You have been diagnosed with pancreatic, lung, or colorectal cancer.
- You are willing to sign a consent form and follow the study procedures.
- You do not have severe liver or kidney disease.
- You have not had targeted therapy or radiotherapy recently.
- You have not had major surgery in the last month.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new type of PET scan that uses a special antibody to find a marker called Trop2 on many common solid tumors. It may help doctors see tumors more clearly without needing a biopsy.
This trial is testing a new imaging method using a special tracer (GPA33) to find tumors in people with colorectal, gastric, or pancreatic cancer. It may help doctors see tumors more clearly during a PET scan.
This trial uses a special PET scan to see how well it can find and track different types of cancer. It may help doctors better understand your cancer.
This trial tests a new PET/CT scan using a special tracer to detect cancer that has spread to the lining of the abdomen (peritoneal carcinomatosis) in people with colorectal, stomach, ovarian, or pancreatic cancer. It aims to see if this scan is better at finding the spread than standard imaging.
This trial tests a special PET/CT scan using a new tracer (68Ga-FAPI) to help show tumors in the pancreas, bile ducts, stomach, or certain ovarian cancers. It may help doctors better see where cancer is in preparation for surgery or biopsy.
This trial uses a special PET scan tracer to see how it spreads in the body for people newly diagnosed with pancreatic or head and neck cancer who haven't had treatment yet. It aims to help doctors better understand and potentially treat these cancers.
Hear when a new Tumor, Solid trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.